Life sciences solutions provider Bioclinica acquires Saliency

Bioclinica, a solutions provider of clinical life science and technology expertise, has acquired Silicon Valley-based Saliency. 

Bioclinica will integrate the company's AI technology into its imaging platform to support a growing portfolio of pharmaceutical and medical device clients. The integration will aims to accelerate image QC and interpretation, enabling rapid development of digital diagnostics and digital therapeutics. 

Dan Gebow, chief innovation officer at Bioclinica, said: "Clients rely on us for time-sensitive expert-level image interpretation for their clinical trials so they can focus on outcomes. We evaluated a variety of medical imaging AI platforms and know the Saliency platform is head and shoulders above others in the market in its ability to deliver value for our clients."

The Saliency platform uses algorithms to build and train AI models from a small number of de-identified images. These newly created models can then be used to screen, redact, or interpret medical images to support a range of therapeutic areas. This capability will be embedded into Bioclinica's current and future imaging solutions in accordance with EU GDPR and other privacy regulations.

Kevin Thomas, MD/PhD, CEO of Saliency, said: "This integration empowers industry stakeholders with the absolute latest in medical imaging technology by delivering custom AI models faster and with more accuracy."

The Saliency acquisition solidifies Bioclinica's position as a provider of research image technology and services to sponsors and Clinical Research Organizations. The AI integration will create a perpetual learning system that will enable Bioclinica to expand its portfolio and drive new revenue with its enhanced offering.

Saliency's co-founders, Kevin Thomas, MD/PhD, candidate at Stanford University School of Medicine and Łukasz Kidziński, PhD, formerly of Stanford's Bioengineering & Statistics, will join Bioclinica's Image Science team, further strengthening the company's medical imaging expertise and offerings. 

Łukasz Kidziński, Saliency's president and CTO, said: "We are proud to combine our state-of-the-art cloud-based tools with Bioclinica's unrivalled imaging expertise.”